Inactive Instrument

Press Releases Rubius Therapeutics

Stocks

RUBY

US78116T1034

Press Releases

23-04-06	RUBIUS THERAPEUTICS, INC. : Change in Directors or Principal Officers, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)	AQ
23-03-03	RUBIUS THERAPEUTICS, INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Change in Directors or Principal Officers (form 8-K)	AQ
23-02-27	RUBIUS THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	AQ
23-02-22	RUBIUS THERAPEUTICS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)	AQ
23-02-06	RUBIUS THERAPEUTICS, INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Change in Directors or Principal Officers (form 8-K)	AQ
22-12-21	Rubius Therapeutics : Acquisition/Asset Disposal - Form 8-K	PU
22-12-21	RUBIUS THERAPEUTICS, INC. : Completion of Acquisition or Disposition of Assets (form 8-K)	AQ
22-12-14	Rubius Therapeutics : Termination of Material Agreement - Form 8-K	PU
22-12-14	RUBIUS THERAPEUTICS, INC. : Termination of a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	AQ
22-12-12	RUBIUS THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	AQ
22-11-09	RUBIUS THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	AQ
22-11-02	RUBIUS THERAPEUTICS, INC. : Costs Associated with Exit or Disposal Activities, Change in Directors or Principal Officers (form 8-K)	AQ
22-11-02	Rubius Therapeutics Announces Process to Explore Strategic Alternatives and Leadership Changes	GL
22-10-17	RUBIUS THERAPEUTICS, INC. : Change in Directors or Principal Officers (form 8-K)	AQ
22-10-13	Rubius Therapeutics : Accelaration/Increase of Financial Obligation - Form 8-K	PU
22-10-13	RUBIUS THERAPEUTICS, INC. : Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement (form 8-K)	AQ
22-09-19	Rubius Therapeutics to Present at Guggenheim Nantucket Therapeutics Conference	GL
22-09-19	Rubius Therapeutics to Present at Guggenheim Nantucket Therapeutics Conference	AQ
22-09-13	RUBIUS THERAPEUTICS, INC. : Costs Associated with Exit or Disposal Activities, Other Events, Financial Statements and Exhibits (form 8-K)	AQ
22-09-13	Rubius Therapeutics Announces Strategic Update	AQ
22-09-13	Rubius Therapeutics Announces Strategic Update	GL
22-09-12	Rubius Therapeutics to Provide Strategic Update	GL
22-09-12	Rubius Therapeutics to Provide Strategic Update	AQ
22-08-12	RUBIUS THERAPEUTICS, INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Change in Directors or Principal Officers (form 8-K)	AQ
22-08-10	Rubius Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Update	AQ